$ITCI Intra-Cellular Therapies, Inc. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Intra-Cellular Therapies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in Intra-Cellular Therapies, Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
Intra-Cellular Therapies, Inc. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| ALAFI CAPITAL CO LLC | 10% Owner | 3,953,270 | 57,480,546 | Oct 03 2017 | |||
| ALAFI CAPITAL CO LLC | 10% Owner | 3,596,205 | 52,288,821 | Dec 03 2014 | |||
| Alafi Christopher D | Director | 133,843 | 1,946,077 | May 28 2021 | |||
| Alafi Christopher D | Director | 2,604 | 37,862 | Jan 05 2015 | |||
| ALAFI MOSHE | 10% Owner | 3,953,270 | 57,480,546 | Oct 03 2017 | |||
| ALAFI MOSHE | 10% Owner | 3,596,205 | 52,288,821 | Dec 03 2014 | |||
| Davis Robert E | SVP, Chief Scientific Officer | 46,691 | 678,887 | Jan 08 2019 | |||
| Durgam Suresh K. | Chief Medical Officer | 25,838 | 375,685 | Feb 25 2021 | |||
| Fienberg Allen A. | VP of Business Development | 197,823 | 2,876,346 | Sep 11 2015 | |||
| Halstead Michael | EVP and General Counsel | 11,139 | 161,961 | Feb 25 2021 | |||
| Halstead Michael | SVP and General Counsel | 20,000 | 290,800 | Jan 06 2015 | |||
| Hineline Lawrence J. | SVP of Finance CFO | 10,442 | 151,827 | Feb 25 2021 | |||
| LERNER RICHARD A | Director | 95,894 | 1,394,299 | Apr 02 2021 | |||
| LERNER RICHARD A | Director | 2,087 | 30,345 | Jan 05 2015 | |||
| MARCUS JOEL S | Director | 67,269 | 978,091 | Jun 15 2021 | |||
| MARCUS JOEL S | Director | 2,668 | 38,793 | Jan 05 2015 | |||
| Mates Sharon | Chairman, President & CEO | 1,161,239 | 16,884,415 | Feb 25 2021 | |||
| Neumann Mark | EVP, Chief Commercial Officer | 50,523 | 734,604 | Feb 22 2021 | |||
| Rawlins Michael | Director | 0 | 0 | Jul 02 2014 | |||
| RIGGS RORY B | Director | 61,941 | 900,622 | Apr 02 2021 | |||
| Sanchez Juan F. | VP, Corp. Communications & IR | 0 | 0 | Jan 06 2015 | |||
| Satlin Andrew | EVP and Chief Medical Officer | 22,911 | 333,126 | Feb 20 2020 | |||
| Sosland Morton I. | 10% Owner | 2,198,554 | 31,966,975 | Mar 12 2015 | |||
| VAN NOSTRAND ROBERT L | Director | 8,273 | 120,289 | Apr 02 2021 | |||
| VAN NOSTRAND ROBERT L | Director | 929 | 13,508 | Jan 05 2015 | |||
| VAN NOSTRAND ROBERT L | Director | 0 | 0 | Mar 24 2014 | |||
| Vanover Kimberly E. | SVP, Early Stage Clinical Dev. | 37,224 | 541,237 | Jan 08 2019 | |||
| Wennogle Lawrence P. | Vice President, Drug Discovery | 126,500 | 1,839,310 | Jun 09 2015 |